INTRODUCTION
The liver is mainly composed of two epithelial cell types, hepatocytes and ductal cells. Hepatocytes synthesize essential serum proteins, control metabolism, and detoxify a wide variety of endogenous and exogenous molecules (Duncan et al., 2009) . Despite their considerable replication capacity in vivo (Michalopoulos, 2014) , hepatocytes have resisted long-term expansion in culture (Mitaka, 1998) . Indeed, a recent study describes a human liver hepatocyte culture system for a period of $1 week with only 10-fold expansion (Shan et al., 2013) . As an alternative, human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) cells have been differentiated toward hepatocyte-like cells. However, recent reports imply that genetic and epigenetic aberrations occur during the derivation and reprogramming processes (Liang and Zhang, 2013; Pera, 2011; Lund et al., 2012) . These range from chromosomal abnormalities (Laurent et al., 2011) ,''de novo'' copy number variations (CNVs) (Hussein et al., 2011) , and point mutations in protein-coding regions (Gore et al., 2011) . Such changes may complicate their use for regenerative medicine purposes (Bayart and Cohen-Haguenauer, 2013 ).
We have recently described a culture system that allows the long-term expansion (>1 year) of single mouse adult intestine (Sato et al., 2009) , stomach (Barker et al., 2010) , liver (Huch et al., 2013b) , and pancreas (Huch et al., 2013a ) stem cells. Lgr5, the receptor for the Wnt agonists R-spondins (Carmon et al., 2011; de Lau et al., 2011) , marks adult stem cells in these mouse tissues (Barker et al., 2007 (Barker et al., , 2010 Huch et al., 2013a Huch et al., , 2013b . These cultures remain committed to their tissue of origin. We have recently adapted the technology to allow culturing of human intestinal stem cells (Jung et al., 2011; Sato et al., 2011) and have shown that patient-derived intestinal organoids recapitulate the pathology of hereditary intestinal diseases (Bigorgne et al., 2014; Dekkers et al., 2013; Wiegerinck et al., 2014) . Here, we pursue the establishment of an organoid culture system for human liver. 
RESULTS

Optimization of Human Liver Stem Cell Culture
Our defined mouse liver medium (ERFHNic [Huch et al., 2013b] ) supported the growth of human liver cells only for 2-3 weeks ( Figure 1A and 1B and Figure S1A , top, available online). Gene expression profiles of human liver cultures that were maintained for 2 weeks in ''mouse liver medium'' revealed highly active Tgf-b signaling. Tgf-b target genes such as CTGF, PLAT, TIMP1, and TIMP2 were highly expressed, whereas Tgf-b sequesters (LTBP2 and LTBP3) and Smad4 inhibitors (SMURF1 and SMURF2) (Massagué et al., 2005) were virtually absent (Figure S1B) . Tgf-b signaling induces growth arrest and epithelialto-mesenchymal transition (Xu et al., 2009) . Specific inhibition of Tgf-b receptors Alk4/5/7 by the small molecule inhibitor A8301 downregulated CTGF, TIMP2, and PLAT ( Figure S1C ), extended the time in culture ($6-7 weeks, six to seven splits) ( Figure 1B ), and enhanced colony-forming efficiency ( Figure 1D ). Still, the cultures eventually deteriorated (Figures 1B and 1C, left) . Expression of the stem cell marker LGR5 decreased over time, whereas differentiation markers such as Albumin (ALB) or CYP3A4 were upregulated (data not shown), indicating that our conditions were promoting differentiation. We then tested additional compounds to induce proliferation and/or LGR5 expression (Table S1 ). Proliferating bile-duct progenitor cells occur both during homeostasis (Furuyama et al., 2011) and after damage Huch et al., 2013b; Shin et al., 2011) . As Forskolin (FSK), a cAMP pathway agonist, induces proliferation of biliary duct cells in vivo (Francis et al., 2004) , we asked whether cAMP would support the human liver cultures.
FSK addition upregulated LGR5 and the ductal marker KRT19, whereas ALB and CYP3A4 decreased ( Figure S1D ). Colonyforming efficiency was essentially unchanged ( Figure 1D ), yet the cultures expanded as budding organoids for many months in culture (>6 months) at a weekly split ratio of 1:4-1:6 (Figures 1B and 1C, right) . Similar results were observed with other cAMP agonists (8-BrcAMP, Cholera toxin or NKH477) (Figure S1E) . Removal of cAMP agonists resulted in rapid deterioration ( Figures S1F and S1G) . Similarly, removal of the Wnt agonist R-spo or blocking Wnt secretion by porcupine inhibition (IWP-2) resulted in rapid loss of the cultures (Figures S1F-S1H ). This effect was rescued by exogenous addition of Wnt ( Figure S1H ). Twelve additional healthy human donor liver biopsies were cultured in the improved medium, with a consistent doubling time of $60 hr, independent of the age of the culture (Figures  1E and 1F and Table S2 ). EdU incorporation confirmed that the cells maintained their proliferative state in vitro ( Figure 1G ) for >3 months. Cultures could be readily frozen and thawed (data not shown). Thus, Wnt signals, cAMP activation, and Tgf-b inhibition were essential for long-term expansion.
Organoids Originate from Ductal cells
Collagenase perfusion of donor livers yields high numbers of fresh, viable, and functional human hepatocytes (Gramignoli et al., 2012) (Figure S2A ). We employed EpCAM to differentially sort hepatocytes (EpCAM À ) from ductal EpCAM + ductal cells ( Figures 1H, S2B , and S2C) (Schmelzer et al., 2007; Yoon et al., 2011) . Although hepatocytes formed no organoids, Ep-CAM + bile duct cells developed into organoids with a striking efficiency of 28.4% ± 3.2% ( Figures 1H, S2D , and S2E). Crude liver cell preparations grew into organoid structures with an efficiency that equaled the number of EpCAM + cells (Figures S2F and S2G) . In our culture system, ductal cells rather than hepatocytes initiate organoids.
Clonal Organoids Are Genetically Stable
Organoids cultured for 3 months maintained normal chromosome numbers ( Figures 3A and S4A) . From two donors, we obtained biopsy samples, which we dissociated and cultured in bulk for 7 days. Subsequently, we isolated single cells and established two independent clonal lines for each of the two livers (cultures A and B). After 3 months of expanding these cultures, a second cloning step was performed. We could thus determine all genomic variation accumulated in a single cell during life, derivation, and 3 months of culture (Figures 2A and 2B) .
We observed 720-1,424 base substitutions per cultures, of which 63-139 were introduced during the 3 months culture ( Figure 2C ). Therefore, the majority of the base substitutions identified had been incorporated in vivo (during life) or introduced during organoid derivation, but not during culture. How do these numbers compare to published data? iPS cells contain 1,058-1,808 de novo base substitutions (determined at passage numbers between 15 and 25) compared to their parental somatic (E-G) Expansion rates, in vitro growth curves, and EdU incorporation were analyzed at early and late passages in EM. (E and F) Graphs illustrate the number of cells counted per well at each passage from P1-P4 (E) to P16-P18 (F). Results are expressed as mean ±SEM of three independent cultures. The doubling time was calculated as described in the Extended Experimental Procedures. (G) EdU incorporation was still detected at late passages. (H) Human liver cell suspensions were separated into EpCAM+ ductal cells and larger EpCAMÀ hepatocytes (for exact gating strategy, see Figure S2C ). Identity of the populations was confirmed by staining for Albumin and KRT19. Sorted cells were grown for 14 days. Organoids were exclusively derived from EpCAM+ ductal cells. See also Figures S1 and S2.
cells (Cheng et al., 2012) . Of note, the numbers from these studies do not include the variation acquired in vivo in the parental somatic cells. Thus, 3 months of in vitro expansion of liver organoids introduces 10-fold fewer base substitutions than iPS cell reprogramming. Of the total number of base substitutions, only few were located in protein-coding DNA (seven to nine base substitutions per culture; Figures 2D and S3 ). With the exception of one synonymous mutation in culture A from donor 2 (Table S3) , all mutations were already present in the early passage clonal cultures, indicating that they were not (B) Schematic overview of the experimental setup. Two independent donor liver biopsies were cultured for 1 week. Single cells were then clonally expanded to obtain two independent organoid cultures per donor (cultures A and B). After long-term expansion, a second clonal expansion step was performed. The resulting organoid cultures were subjected to WGS analysis. To obtain all somatic variation, variants were filtered for presence in the original biopsy. To determine the effect of long-term culturing on genomic stability, somatic variation was filtered for presence in earlier passages. 111,500,000 112,000,000 112,500,000 113,000,000 113,500,000
Position on chromosome 3 111,500,000 112,000,000 112,500,000 113,000,000 113,500,000
Variant allele frequenty SNPs incorporated during the 3 months of expansion. None of the mutated genes occurs in COSMIC databases (Table S3) . In iPS cells, an average of six base substitutions per line affect protein-coding DNA (Cheng et al., 2012; Gore et al., 2011) . Next, we searched for structural aberrations in the WGS data. We did not observe any gross chromosomal aberrations (Figure 3B) . We observed two copy number variants (CNVs), heterozygous gains, in one of the liver organoid cultures (Figures 3C) . In the other cultures, we did not detect any CNV . Moreover, these two CNVs were already present in the early passage cultures and therefore did not result from long-term culturing. ES cell cultures routinely show abnormal karyotypes (Baker et al., 2007) , and iPS cells can harbor considerable numbers of somatic CNVs (Hussein et al., 2011; Laurent et al., 2011; Martins-Taylor et al., 2011; Mayshar et al., 2010; Abyzov et al., 2012) .
Differentiation into Functional Hepatocytes In Vitro and upon Transplantation
The stem cell markers PROM1 and LGR5, as well as ductal (SOX9, OC2) and hepatocyte markers (HNF4a) were readily expressed ( Figures 4A, S5A , and S5B). Histologically, liver organoids displayed a duct-like phenotype presenting either as: (1) a single-layered epithelium, expressing the cytokeratin markers KRT19 and KRT7, or (2) a pseudo-stratified epithelium with nonpolarized E-Cadherin + HNF4a+ and some KRT7+ cells ( Figures   4B-4D ). SOX9 ( Figure 4E ) and EPHB2 ( Figure 4F ) were detectable in almost all cells, whereas LGR5 was detectable within the EPHB2+ population ( Figure 4F ). The organoids failed to express markers of mature hepatocytes, such as Albumin or CYP3A4 (Figures 4A and 5C, EM bars). Therefore, we defined a human differentiation medium (DM) ( Table S1 ). Removal of the growth stimuli R-spo and FSK resulted in upregulation of Albumin and CYP3A4 ( Figure S5C ). To this medium, we then added the Notch inhibitor DAPT (Huch et al., 2013b) , FGF19 (Wu et al., 2011) , and dexamethasone (Rashid et al., 2010) (Figure S5D ). BMP7 reportedly accelerates hepatocyte proliferation in vivo (Sugimoto et al., 2007) . Addition of BMP7 slightly facilitated the expression of hepatocyte markers ALB and CYP3A4 even during expansion medium (data not shown). Therefore, 5-7 days prior to the start of differentiation, we added 25 ng/ml BMP7 to the expansion medium (EM) ( Figure 5A ). When cultured in this differentiation medium (DM), the cells acquired pronounced hepatocyte morphologies, including polygonal cell shapes ( Figure 5B ). Gene expression profiles revealed high levels of hepatocyte markers such as ALB, cytochromes, Apolipoproteins (APOB), and complement factors (C3) (Figures 5C, 5D, and S5E) . Cells with high levels of ALB and MRP4 were detected by immunofluorescence ( Figure 5B ). Similar results were obtained with cultures derived from EpCAM + -sorted ductal cells ( Figures S5F and S5G ). Immunohistochemical analysis indicated that the cells accumulate glycogen ( Figure 6A ) and take up LDL ( Figure 6B ). Albumin was secreted into the medium ( Figure 6C ). The cultures exhibited similar CYP3A4 activity as fresh isolated hepatocytes ( Figure 6D , compare to Figure S2A ). Differentiated organoids hydroxylated midazolam, another indication of functional CYP3A3/4/5 activity (Wandel et al., 1994) , and glucuronidated hydroxy-midazolam, thereby showing evidence of both phase I and II detoxifying reactions ( Figure 6E ). Bile acid salts were readily secreted into the medium ( Figure 6F ). Finally, the organoids detoxified ammonia at similar levels to HepaRG cells ( Figure 6G ). In all cases, the expanded human liver organoids showed stronger hepatocyte functions when compared to the standard/reference cell line HepG2 cells ( Figure 6 ).
To test the ability of the organoids to engraft as functional hepatocytes in vivo, we treated Balb/c nude mice with CCl4-retrorsine to induce acute liver damage. This treatment allows engraftment of hepatocytes (Guo et al., 2002; Schmelzer et al., 2007) . Using human-specific antibodies ( Figure S6A ), we initially detected KRT19-positive, ductal-like cells at 2 hr and 2 days after transplantation, distributed throughout the liver parenchyma ( Figure S6B ). At later time points, we observed ALB + ,
KRT19
À human cells as singlets/doublets or, more rarely, in larger hepatocyte foci ( Figures 6H and S6C ). Of note, our damage model provides no stimulus for expansion of the transplant after engraftment. Human Albumin and a-1-antitrypsin were found in serum of recipient mice within 7-14 days (Figures 6I, S6D, and S6E) at a level that remained stable for more than 60 days in five out of six mice and for more than 120 days in two out of five animals. Although transplantation of primary human hepatocytes initially yielded higher levels of human Albumin ( Figure 6I ), the levels approximated those of transplanted organoids within a month.
Patient Organoids Model Disease Pathogenesis a1-antitrypsin (A1AT) deficiency is an inherited disorder that predisposes to chronic obstructive pulmonary disease and chronic liver disease (Stoller and Aboussouan, 2005) . A1AT is secreted from the liver to protect the lung against proteolytic damage from neutrophil elastase. The most frequent mutation is the Z allele (Glu342Lys) of the SERPINA1 gene, which causes accumulation of misfolded A1AT in hepatocytes. The ZZ mutant phenotype is characterized by a $80% reduction of the protein in plasma, which subsequently causes lung emphysema (Stoller and Aboussouan, 2005) . Biopsies from three patients diagnosed with A1AT deficiency (Table S2 and Figure S7A ) were subjected to histological characterization, RNA, and DNA isolation and expansion in culture. Organoids were grown for >4 months in culture and behaved normally. Gene expression analysis demonstrated that the cells differentiated normally in DM (Figure S7B ). Functional tests revealed that the differentiated cells from A1AT patients secreted high levels of Albumin and take up LDL similar to that of healthy donor-derived organoid cultures ( Figures 7B-7D) . In A1AT deficiency, the molecular pathogenesis of the liver disease relates to the aggregation of the protein within the endoplasmic reticulum of hepatocytes (Lawless et al., 2008) . A1AT protein aggregates were readily observed within the cells of the differentiated organoids ( Figure 7H) , similar to what was found in the original biopsy ( Figure 7G ). A1AT ELISA confirmed reduced protein secretion ( Figure 7I ) (Table S2 indicates the A1AT secretion per patient), and supernatants from differentiated mutant organoids showed reduced ability to block elastase activity ( Figure 7J ). Protein misfolding is one of the primary causes that drive hepatocytes apoptosis in PiZZ individuals (Lawless et al., 2008) . Differentiated liver organoids from A1AT-D patients mimicked the in vivo situation and showed signs of ER stress, such as phosphorylation of eIF2a ( Figure 7K ) and increased apoptosis in the differentiated state ( Figures S7C  and S7D ). Using a biopsy from an Alagille syndrome (AGS) patient, we tested whether structural defects of the biliary tree can also be modeled. AGS is caused by mutations in the Notch-signaling pathway, which results in partial to complete biliary atresia (Kamath et al., 2013 Nicotinamide, TGFbi, and FSK, AGS patient organoids failed to upregulate biliary markers such as KRT19 and KRT7 (Figure S7E) . Staining for KRT19 revealed that biliary cells were scarce and unable to integrate into the epithelium. Rather, they rounded up and underwent apoptosis in the organoid lumen ( Figure S7F ). In AGS mouse models, JAGGED-1/NOTCH2 is dispensable for biliary lineage specification but is required for biliary morphogenesis (Geisler et al., 2008; McCright et al., 2002) . Thus, AGS liver organoids constitute the first human 3D model system to study Alagille syndrome.
DISCUSSION
Liver diseases (ranging from genetic inherited disorders to viral hepatitis, liver cancer, and obesity-related fatty liver disease) account for the twelfth-leading cause of death in the United States (Heron, 2012) . Failure in the management of liver diseases can be attributed to the shortage of donor livers (Vilarinho and Lifton, 2012) as well as to our poor understanding of the mechanisms behind liver pathology. The value of any cultured cell as a disease model or as a source for cell therapy transplantation depends on the fidelity and robustness of its expansion potential as well as its ability to maintain a normal genetic and epigenetic status (Pera, 2011) . The possibility of differentiating hESC or reprogrammed fibroblasts (iPS) into almost any differentiated cell type, from neurons to hepatocytes, has allowed modeling of many human genetic diseases, including A1AT-D (Rashid et al., 2010) . However, the genetic instability of cultured stem cells raises concerns regarding their safe use in cell therapy transplantation (Bayart and Cohen-Haguenauer, 2013) . Here, we show that primary human bile duct cells can readily be expanded in vitro as bipotent stem cells into 3D organoids. These cells differentiate into functional hepatocyte cells in vitro and generate bona fide hepatocytes upon transplantation. Extensive analysis of the genetic stability of cultured organoids in vitro demonstrates that the expanded cells preserve their genetic integrity over months in culture. These results agree with our previous observations in the mouse (Huch et al., 2013b) yet are in striking contrast to recent publications in which, utilizing several lineage tracing approaches, ductal/resident stem cells have been described as not contributing to mouse liver regeneration (Schaub et al., 2014; Yanger et al., 2014; Yanger et al., 2013) . Our results resemble what has been elegantly shown in zebrafish and rat models: in the event of an almost complete hepatocyte loss or blockage of hepatocyte proliferation, biliary epithelial cells convert into hepatocytes (Choi et al., 2014) (Michalopoulos, 2014) . Our data are further corroborated in human fulminant hepatic failure, in which, upon 80% loss of hepatocyte compartment, huge numbers of proliferating EpCAM+ biliary epithelial cells are observed (Hattoum et al., 2013) .
Organoids from A1AT-deficiency patients can be expanded in vitro and mimic the in vivo pathology. Similarly, organoids from an Alagille syndrome patient reproduce the structural duct defects present in the biliary tree of these patients. Repair by homologous recombination using CRISPR/Cas9 technology is feasible in organoid cultures, as we recently demonstrated in colon stem cells of cystic fibrosis patients (Schwank et al., 2013) . A variety of monogenic hereditary diseases affect the liver specifically, and these should all be amenable to a comparable in vitro approach of gene repair in clonal liver progenitor cells. Overall, our results open up the avenue to start testing human liver material expanded in vitro as an alternative cell source for studies of human liver regeneration, human liver disease mechanism, cell therapy transplantation, toxicology studies, or drug testing.
EXPERIMENTAL PROCEDURES
Human Liver Organoid Culture Liver biopsies (0.5-1 cm 3 ) were obtained from donor and explant livers during liver transplantation performed at the Erasmus MC, Rotterdam. The Medical Ethical Council of the Erasmus Medical Center approved the use of this material for research purposes, and informed consent was provided from all patients. For EpCAM sorting experiments and hepatocyte isolation, primary human liver tissue was obtained with informed consent and approval by the Regional Ethics Board, from the CLINTEC division of Karolinska institute (Dnr: 2010/678-31/3) (Jorns et al., 2014) . Liver cells were isolated from human liver biopsies (0.5-1 cm 3 ) by collagenase-accutase digestion, as described in the Extended Experimental Procedures. The different fractions were mixed and washed with cold Advanced DMEM/F12 and spun at 300-400 3 g for 5 min. The cell pellet was mixed with Matrigel (BD Biosciences) or reduced growth factor BME 2 (Basement Membrane Extract, Type 2, Pathclear), and 3,000-10,000 cells were seeded per well in a 48-well/plate. Non-attaching plates were used (Greiner). After Matrigel or BME had solidified, culture medium was added. Culture media was based on AdDMEM/F12 (Invitrogen) supplemented with 1% N2 and 1% B27 (both from GIBCO), 1.25 mM NAcetylcysteine (Sigma), 10 nM gastrin (Sigma), and the growth factors: 50 ng/ml EGF (Peprotech), 10% RSPO1 conditioned media (homemade), 100 ng/ml FGF10 (Peprotech), 25 ng/ml HGF (Peprotech), 10 mM Nicotinamide (Sigma), 5 uM A83.01 (Tocris), and 10 uM FSK (Tocris). For the establishment of the culture, the first 3 days after isolation, the medium was supplemented with 25 ng/ml Noggin (Peprotech), 30% Wnt CM (homemade prepared as described in Barker et al. [2010] ), and 10 uM (Y27632, Sigma Aldrich) or hES cell cloning recovery solution (Stemgent). Then, the medium was changed into a medium without Noggin, Wnt, Y27632, hES cell cloning recovery solution. After 10-14 days, organoids were removed from the Matrigel or BME, mechanically dissociated into small fragments, and transferred to fresh matrix. Passage was performed in a 1:4-1:8 split ratio once every 7-10 days for at least 6 months. To prepare frozen stocks, organoid midazolam glucuronide were determined. Duplicates for each condition and donor were analyzed. Results are shown as mean ±SEM of two independent experiments. (F) Bile acid production shown as ±SEM of two independent experiments in two independent donor-derived cultures. Duplicates for each condition and donor were analyzed. (G) Ammonia elimination, shown as ±SEM of n = 3 independent experiments in two independent donor-derived cultures, given as nM/h/million cells. cultures were dissociated and mixed with recovery cell culture freezing medium (GIBCO) and frozen following standard procedures. When required, the cultures were thawed using standard thawing procedures and cultured as described above. For the first 3 days after thawing, the culture medium was supplemented with Y-27632 (10 mM). Growth curves and expansion ratios were performed and calculated as described in the Extended Experimental Procedures.
Isolation of EpCAM+ Cells and Single-Cell Culture Cell suspensions prepared as described in the Extended Experimental Procedures were stained with anti-human CD326 (EpCAM), sorted on a MoFlo (Dako Cytomation) sorter, and cultured as described above with medium supplemented with Y-27632 (10 mM, Sigma Aldrich) for the first 4 days. Passage was performed in split ratios of 1:4-1:8 once per week.
For clonogenic assays, single-cell suspensions were sorted using FSC and pulse width to discriminate single cells. Propidium iodide staining was used to label dead cells and FSC: pulse-width gating to exclude cell doublets (MoFlow, Dako). Sorted cells were embedded in Matrigel and seeded in 96-well plates at a ratio of 1 cell/well. Cells were cultured as described above.
Hepatocyte Differentiation and In Vitro Functional Studies
Liver organoids were seeded and kept 7-10 days under the liver medium explained above (EM, expansion medium) supplemented with BMP7 (25 ng/ml). Then, the cultures were split and seeded accordingly in this EM supplemented with BMP7 for at least 2-4 days. Then, medium was changed to the differentiation medium (DM): AdDMEM/F12 medium supplemented with 1% N2 and 1% B27 and containing EGF (50 ng/ml), gastrin (10 nM, Sigma), HGF (25 ng/ml), FGF19 (100 ng/ml), A8301 (500 nM), DAPT (10 uM), BMP7 (25 ng/ml), and dexamethasone (30 uM). Differentiation medium was changed every 2-3 for a period of 11-13 days.
To assess hepatocyte function, culture medium was collected 24 hr after the last medium change. Functional studies were performed in the collected supernatant or in whole organoids, as described in the Extended Experimental Procedures.
Transplantation
We used a modified version of the protocol used by Guo et al. (Guo et al., 2002) . In short, female BALB/c nude mice (around 7 weeks of age) were pretreated with two injections of 70 mg/kg Retrorsine (Sigma) at 30 and 14 days before transplantation. One day prior to transplantation, mice received 0.5 ml/kg CCl4 and 50 mg/animal anti-asialo GM1 (Wako Pure Chemical Industries) via IP injection. Furthermore, animals received 7.5 ug/ml FK506 in drinking water until the end of the experiment due to the reported positive effects on liver regeneration (He et al., 2010) . On the day of transplantation, mice were anaesthetized, and suspensions of 1-2 3 10 6 human liver organoid cells derived from four independent donors (p6-p10) or fresh isolated hepatocytes (two donors) were injected intrasplenically. Transplanted mice received weekly injections of 50 mg/animal anti-asialo GM1 (Wako Pure Chemical Industries) to deplete NK cells. To monitor the transplantation state, blood samples were taken in regular intervals from the tail vein and were analyzed for the presence of human albumin and human a1-antitrypsin using respective human specific ELISAs (Assaypro).
Karyotyping and Genetic Stability Analysis
Organoid cultures in exponential growing phase were incubated for 16 hr with 0.05 mg/ml colcemid (GIBCO). Then, cultures were dissociated into single cells using TrypLE express (GIBCO) and processed using standard karyotyping protocols. DNA libraries for WGS analysis were generated from 1 mg of genomic DNA using standard protocols (Illumina). The libraries were sequenced with pairedend (2 3 100 bp) runs using Illumina HiSeq 2500 sequencers to a minimal depth of 303 base coverage (average depth of $36.93 base coverage). As a reference sample, liver biopsies was sequenced to equal depth for the different donors. Analysis of the sequence reads, calling of CNVs, and base substitutions are described in detail in the Extended Experimental Procedures. The data for the whole-genome sequencing were deposited to the EMBL European Nucleotide Archive with accession number ERP005929.
Immunohistochemistry, Immunofluorescence, and Image Analysis Tissues and organoids were fixed o/n with formalin or 4% PFA, respectively, and stained and imaged as described in the Extended Experimental Procedures.
A1AT-D Functional Experiments
Elastase inhibition assay and detection of phosphorylated eIF2a were performed as described in the Extended Experimental Procedures.
Microarray
For the expression analysis of human liver cultures, total RNA was isolated from liver biopsies or from organoid cultures grown in our defined medium, using QIAGEN RNAase kit following the manufacturer's instructions. Five hundred ng of total RNA were labeled with low RNA Input Linear Amp kit (Agilent Technologies). Universal human reference RNA (Agilent) was differentially labeled and hybridized to the tissue or cultured samples. A 4X 44 K Agilent whole human genome dual color microarray (G4122F) was used. Labeling, hybridization, and washing were performed according to Agilent guidelines. Microarray signal and background information were retrieved using Feature Extraction software (V.9.5.3, Agilent Technologies). Hierarchical clustering analysis was performed in whole-liver tissue or organoid arrays. A cut-off of 3-fold differentially expressed was used for the clustering analysis.
Data Analysis
All values are represented as mean ± SEM. Man-Whitney nonparametric test was used. p < 0.05 was considered statistically significant. In all cases, data from at least three independent experiments was used. All calculations were performed using SPSS package.
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